Why Is PharmaCyte Biotech Stock Moving Higher In Premarket Thursday?
The stock price of PharmaCyte Biotech Inc (NASDAQ: PMCB) is trading higher during premarket today.
Investors are expecting a major announcement from the company today.
PharmaCyte Biotech Establishes 18-Month Shelf Life For Clinical Trial Product In Ongoing Stability Study
PharmaCyte Biotech, Inc. (NASDAQ:PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today
PharmaCyte Biotech Expands Product Pipeline To Include Diabetes, Malignant Ascites Following $90M Capital Raise
PharmaCyte Biotech, Inc. (NASDAQ:PMCB) (PharmaCyte or Company), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology,
60 Biggest Movers From Yesterday
Gainers
Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value of $2.26 billion.
35 Stocks Moving In Monday’s Mid-Day Session
Gainers
Trillium Therapeutics Inc. (NASDAQ: TRIL) shares climbed 187.8% to $17.53 after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value of $2.26 billion.
22 Stocks Moving in Friday’s Pre-Market Session
Gainers
GeoVax Labs, Inc.. (NASDAQ: GOVX) shares rose 72.1% to $7.40 in pre-market trading after the company announced it presented COVID-19 vaccine data at the European Society of Medicine General Assembly.
Mid-Afternoon Market Update: Dow Falls 170 Points; DLocal Shares Spike Higher
Toward the end of trading Thursday, the Dow traded down 0.49% to 34,790.15 while the NASDAQ fell 0.07% to 14,515.39. The S&P also fell, dropping 0.14% to 4,394.20.